AtriCure Inc. (ATRC) PT Raised to $36 at Needham & Company
Needham & Company raised its price target on AtriCure Inc. (NASDAQ: ATRC) to $36.00 (from $32.00) while maintaining a Buy ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
